Literature DB >> 27929733

Antibody repertoire profiling with mimotope arrays.

Shina Pashova1, Christoph Schneider2, Stephan von Gunten2, Anastas Pashov3.   

Abstract

Large-scale profiling and monitoring of antibody repertoires is possible through next generation sequencing (NGS), phage display libraries and microarrays. These methods can be combined in a pipeline, which ultimately maps the antibody reactivities onto defined arrays of structures - peptides or carbohydrates. The arrays can help analyze the individual specificities or can be used as complex patterns. In any case, the targets recognized should formally be considered mimotopes unless they are proven to be epitopes driving the antibody synthesis. Here, the advantages and disadvantages of the major profiling techniques as well as their current and future application in disease prediction and vaccination are discussed.

Entities:  

Keywords:  NGS; antibody repertoire; glycan; microarray; peptide; phage display

Mesh:

Substances:

Year:  2016        PMID: 27929733      PMCID: PMC5328411          DOI: 10.1080/21645515.2017.1264786

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  96 in total

Review 1.  A guide into glycosciences: How chemistry, biochemistry and biology cooperate to crack the sugar code.

Authors:  Dolores Solís; Nicolai V Bovin; Anthony P Davis; Jesús Jiménez-Barbero; Antonio Romero; René Roy; Karel Smetana; Hans-Joachim Gabius
Journal:  Biochim Biophys Acta       Date:  2014-03-28

Review 2.  Natural antibodies target virus-antibody complexes to organized lymphoid tissue.

Authors:  Matthias S Matter; Adrian F Ochsenbein
Journal:  Autoimmun Rev       Date:  2008-04-23       Impact factor: 9.754

Review 3.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 4.  Using glycan microarrays to understand immunity.

Authors:  Connie M Arthur; Richard D Cummings; Sean R Stowell
Journal:  Curr Opin Chem Biol       Date:  2014-01-29       Impact factor: 8.822

5.  Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior.

Authors:  Catherine A St Hill; Katherine Krieser; Mariya Farooqui
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

6.  Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.

Authors:  Lai-Xi Wang; Jiahong Ni; Suddham Singh; Hengguang Li
Journal:  Chem Biol       Date:  2004-01

7.  A practical total synthesis of globo-H for use in anticancer vaccines.

Authors:  Insik Jeon; Karthik Iyer; Samuel J Danishefsky
Journal:  J Org Chem       Date:  2009-11-06       Impact factor: 4.354

8.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

9.  Physical characterization of the "immunosignaturing effect".

Authors:  Phillip Stafford; Rebecca Halperin; Joseph Bart Legutki; Dewey Mitchell Magee; John Galgiani; Stephen Albert Johnston
Journal:  Mol Cell Proteomics       Date:  2012-01-18       Impact factor: 5.911

Review 10.  Tumors: too sweet to remember?

Authors:  H Peter Vollmers; Stephanie Brändlein
Journal:  Mol Cancer       Date:  2007-12-04       Impact factor: 27.401

View more
  2 in total

1.  Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome.

Authors:  Shina Pashova; Lubomir Balabanski; Gabriel Elmadjian; Alexey Savov; Elena Stoyanova; Velizar Shivarov; Peter Petrov; Anastas Pashov
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

2.  Enhanced Pro-apoptotic Effects of Fe(II)-Modified IVIG on Human Neutrophils.

Authors:  Stefanie Graeter; Christoph Schneider; Daniëlle Verschoor; Sandro von Däniken; Frank Seibold; Nikhil Yawalkar; Peter Villiger; Jordan D Dimitrov; David F Smith; Richard D Cummings; Hans-Uwe Simon; Tchavdar Vassilev; Stephan von Gunten
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.